The epidemiology of schizophrenia: Replacing dogma with knowledge;La epidemiología de la esquizofrenia: Reemplazar el dogma con el conocim

Dialogues in Clinical Neuroscience

Volumn 12, Issue 3, 2010, Pages 305-315

  Stilo, Simona A ^a   Murray, Robin M ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Epidemiology; Gene environment interaction; Psychosis; Risk factor; Schizophrenia

Indexed keywords

CANNABIS; DOPAMINE; METHAMPHETAMINE;

ARTICLE; ASPHYXIA; BULLYING; CESAREAN SECTION; CHILD ABUSE; CONGENITAL MALFORMATION; DIABETES MELLITUS; DRUG ABUSE; FAMILY HISTORY; GENETIC EPIDEMIOLOGY; GENOTYPE ENVIRONMENT INTERACTION; GEOGRAPHIC DISTRIBUTION; HEAD CIRCUMFERENCE; HUMAN; INCIDENCE; LOW BIRTH WEIGHT; MIGRATION; MORTALITY; OBSTETRICS; ONSET AGE; PARANOID SCHIZOPHRENIA; PARENTAL AGE; PARENTAL DEPRIVATION; PREECLAMPSIA; PREVALENCE; RISK FACTOR; SCHIZOPHRENIA; SEASONAL VARIATION; SOCIAL ISOLATION; URBAN POPULATION; UTERINE ATONY; ADDICTION; AGE; FAMILY HEALTH; PSYCHOSIS; SEX DIFFERENCE; SOCIAL ENVIRONMENT;

AGE FACTORS; AGE OF ONSET; FAMILY HEALTH; HUMANS; PSYCHOTIC DISORDERS; RISK FACTORS; SCHIZOPHRENIA; SEX FACTORS; SOCIAL ENVIRONMENT; SUBSTANCE-RELATED DISORDERS;

EID: 78049511028     PISSN: 12948322     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (125)

1. Peräla J, Suvisaari J, Samuli I, et al. Lifetime prevalence of psychotic and bipolar I disorders in a general population. Arch Gen Psychiatry. 2007;64:19-28.
2. World Health Organization. The ICD-10 Classification of Mental and Behavioral Disorders. Clinical descriptions and diagnostic guidelines. Geneva, Switzerland: World Health Organization; 1992.
3. McGrath J, Saha S, Chant D, Welham J. Schizophrenia: a concise overview of incidence, prevalence, and mortality. Epidemiol Rev. 2008;30:67-76.
4. Cantor-Graae E & Selten JP. Schizophrenia and migration: a meta-analysis and review. Am J Psychiatry. 2005;162:12-24.
5. McGrath JJ. Variations in the incidence of schizophrenia: data versus dogma. Schizophr Bull. 2006;32:195-197.
6. Boydell J, Van Os J, Lambri M, et al. Incidence of schizophrenia in southeast London between 1965 and 1997. Br J Psychiatry. 2003;182:45-49.
7. Kirkbride JB, Fearon P, Morgan C, et al. Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center Aesop study. Arch Gen Psychiatry. 2006;63:250-258.
8. Castle D, Sham P, Murray R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophr Res. 1998;33:179-183.
9. Saha S, Chant D, Welham J, McGrath J. A systematic review of the prevalence of schizophrenia. PloS Med. 2005;2:413-433.
10. Leung A, Chue P. Sex differences in schizophrenia, a review of the literature. Acta Psychiatr Scand Suppl. 2000;401:3-38.
11. Castle DJ, Murray RM. The neurodevelopmental basis of sex differences in Schizophrenia. Psychol Med. 1991;21:565-575.
12. Häfner H, Riecher-Rössler A, An Der Heiden W, Maurer K, Fätkenheuer B, Löffler W. Generating and testing a causal explanation of the gender difference in age at first onset of schizophrenia. Psychol Med. 1993;23:925-940.
13. Tsuang M. Schizophrenia: genes and environment. Biol Psychiatry. 2000;47:210-220.
14. Cardno AG, Marshall J, Coid B, et al. Heritability estimates for psychotic disorders: the Maudsley twin psychosis series. Arch Gen Psych. 1999;56:162-168.
15. Kendler KS, McGuire M, Gruenberg AM, et al. The Roscommon Family Study. I. Methods, diagnosis of probands, and risk of schizophrenia in relatives. Arch Gen Psychiatry. 1993;50:527-540.
16. Gottesman II, Shields J, Hanson DR. Schizophrenia: the Epigenetic Puzzle. Cambridge, UK: Cambridge University Press; 1982.
17. Hare EH, Moran PA. Raised parental age in psychiatric patients: evidence for the constitutional hypothesis. Br J Psychiatry. 1979;134:169-177.
18. Malaspina D, Harlap S, Fennig S, et al. Advancing paternal age and the risk of schizophrenia. Arch Gen Psychiatry. 2001;58:361-367.
19. Torrey EF, Buka S, Cannon TD, et al. Paternal age as a risk factor for schizophrenia: how important is it? Schizophr Res. 2009;114:1-5.
20. Miller B, Messias E, Miettunen J, et al. Meta-analysis of paternal age and schizophrenia risk in male versus female offspring. Schizophr Bull. 2010. In press.
21. Hemminki K, Kyyrönen P. Parental age and risk of sporadic and familial cancer in offspring: implications for germ cell mutagenesis. Epidemiology. 1999;10:747-751.
22. Perrin MC, Brown AS, Malaspina D. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr Bull. 2007;33:1270-1273.
23. Geddes JR, Verdoux H, Takei N, Lawrie SM, Murray RM. Individual patient data meta-analysis of the association between schizophrenia and abnormalities of pregnancy and labour. Schizophr Bull. 1999;25:113-123.
24. Lewis SW, Murray RM. Obstetric complications, neurodevelopmental deviance and risk of schizophrenia. J Psychiatric Res. 1987;21:413-421.
25. McGrath J, Murray RM. Risk factors for schizophrenia: from conception to birth. In: Hirsch S, Weinberger D, eds. Schizophrenia. Oxford, UK: Blackwell;1995:187-205.
26. McNeil TF, Kaij L. Obstetric factors in the development of schizophrenia: complications in the births of preschizophrenics and in reproductions by schizophrenic parents. in: Wynne LC, Cromwell RL, Matthysse S, eds. The Nature of Schizophrenia: New Approaches to Research and Treatment. New York, NY: Wiley; 1978:401-429.
27. Murray RM, Lewis SW, Reveley AM. Towards an aetiological classification of schizophrenia. Lancet. 1985;1:1023-1026.
28. O'Callaghan E, Gibson T, Colohan HA, et al. Risk of schizophrenia in adults born after obstetric complications and their association with early onset of illness: a controlled study. BMJ. 1992;305:1256-1259.
29. Parnas J, Schulsinger F, Teasdale TW, Schulzinger H, Feldman PM, Mednick SA. Perinatal complications and clinical outcome within the schizophrenia spectrum. Br J Psychiatry. 1982;140:416-420.
30. Cannon M, Jones PB, Murray RM. Obstetric complications and schizophrenia: historical and meta-analytic review. Am J Psychiatry. 2002;159:1080-1092.
31. McGrath JJ, Welham L. Season of birth and schizophrenia: a systematic review and meta-analysis of data from the Southern Hemisphere. Schizophr Res. 1999;35:237-242.
32. Jones P, Rantakallio P, Hartikainen AL, Isohanni M, Sipila P. Schizophrenia as a long term outcome of pregnancy and delivery complications: a 28 year follow-up of the 1966 North Finland general population birth cohort. Am J Psychiatry. 1998;155:355-364.
33. Brown AS, Begg MD, Gravenstein S, et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004;61:774-780.
34. Babulas V, Factor-Litvak P, Goetz R, Schaefer CA, Brown AS. Prenatal Exposure to Maternal Genital and Reproductive Infections and Adult Schizophrenia. Am J Psychiatry. 2006;163:927-929.
35. Susser E, Hoek HW, Brown A. Neurodevelopmental disorders after prenatal famine: The story of the Dutch Famine Study. Am J Epidemiol. 1998;147:213-216.
36. Sacker A, Done DJ, Crow TJ, et al. Antecedents of schizophrenia and affective illness. Obstetric complications. Br J Psychiatry. 1995;166:734-741.
37. Hollister JM, Laing P, Mednick SA. Rhesus incompatibility as a risk factor for schizophrenia in male adults. Arch Gen Psychiatry. 1996;53:19-24.
38. Van der Werf M, Van Boxtel M, Verhey F, Jolles J, Thewissen V, Van Os J. Mild hearing impairment and psychotic experiences in a normal aging population. Schizophr Res. 2007;94:180-186.
39. Mason OJ & Brady F. The psychotomimetic effects of short-term sensory deprivation. J Nerv Ment Dis. 2009;197:783-785.
40. Selten JP & Cantor-Graae E. Hypothesis: social defeat is a risk factor for schizophrenia? Br J Psychiatry (Suppl). 2007;51:9-12.
41. Dalman C, Allebeck P, Gunnell D, et al. Infections in the CNS during childhood and the risk of subsequent psychotic illness: a cohort study of more than one million Swedish subjects. Am J Psychiatry. 2008;165:59-65.
42. Murray RM, Doody GA, Philips P, et al. The relationship between substance abuse and schizophrenia. In: Murray RM, Jones PB, Susser E, et al, eds. The Epidemiology of Schizophrenia. Cambridge, UK: Cambridge University Press; 2003:317-342.
43. Curran C, Byrappa N and McBride A. Stimulant psychosis. Br J Psychiatry. 2004;185:196-204.
44. Chen CK, Lin SK, Sham PC, et al. Pre-morbid characteristics and co-morbidity of methamphetamine users with and without psychosis. Psychol Med. 2003;33:1407-1414.
45. Chen CK, Lin SK, Sham PC, Ball D, Lohel-W, Murray RM. Morbid risk for psychiatric disorder among the relatives of methamphetamine users with and without psychosis. Am J Med Genet B Neuropsychiatr Genet. 2005;136B:87-91.
46. Peralta V, Cuesta MJ. Influence of cannabis abuse on schizophrenic psychopathology. Acta Psychiatr Scand. 1992;85:127-130.
47. Hambrecht M, Häfner H. Substance abuse and the onset of schizophrenia. Biol Psychiatry. 1996;40:1155-1163.
48. D'Souza DC, Perry E, MacDougall L, et al. The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis. Neuropsychopharmacology. 2004;29:1558-1572.
49. Morrison PD, Zois V, McKeown DA, et al. The acute effects of synthetic intravenous Delta9-tetrahydrocannabinol on psychosis, mood and cognitive functioning. Psychol Med. 2009;39:1607-1616.
50. Grech A, Van Os J, Jones PB, Lewis SW, Murray RM. Cannabis use and outcome of recent onset psychosis. Eur Psychiatry. 2005;20:349-353.
51. Andreasson S, Allebeck P, Engstromm A, Rydberg U. Cannabis and schizophrenia: a longitudinal study of Swedish conscripts. Lancet. 1987;1483-1485.
52. Arseneault L, Cannon M, Poulton R, et al. Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study. BMJ. 2002;325:1212-1213.
53. Henquet C, Murray R, Linszen D, et al. The environment and schizophrenia: the role of cannabis use. Schizophrenia Bull. 2005;31:608-612.
54. Moore TH, Zammit S, Lingford-Hughes A, et al. Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet. 2007;370:319-328.
55. McGrath J, Welham J, Scott J, et al. Association between cannabis use and psychosis-related outcomes using sibling pair analysis in a cohort of young adults. Arch Gen Psychiatry. 2010;67:440-447.
56. Henquet C, Di Forti M, Morrison P, Kuepper R, Murray RM. Gene-environment interplay between cannabis and psychosis. Schizophr Bull. 2008;34:1111-1121.
57. Arseneault L, Cannon M, Witton J, et al. Causal association between cannabis and psychosis: examination of the evidence. Br J Psychiatry. 2004;184:110-117.
58. Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ. 2005;330:7481-7511.
59. Di Forti M, Morgan C, Dazzan P, et al. High potency cannabis and the risk of psychosis. Br J Psychiatry. 2009;195:488-491.
60. Morrison PD, Murray RM. From real-world events to psychosis: the emerging neuropharmacology of delusions. Schizophr Bull. 2009;35:668-674.
61. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science. 1997;276:2048-2050.
62. Faris REL, Dunham Warren H. Mental Disorders in Urban Areas. An Ecological Study of Schizophrenia and Other Psychoses. Chicago; IL: The University of Chicago Press; 1939:270.
63. Hollingshead A, Redlich RC. Social Class and Mental Illness. London, UK: Wiley; 1958.
64. Harrison J, Barrow S, Creed F. Social deprivation and psychiatric admission rates among different diagnostic groups. Br J Psychiatry. 1995;167:450-462.
65. Allardyce J, Gilmour H, Atkinson J, Rapson T, Bishop J, McCreadie RG. Social fragmentation, deprivation and urbanicity: relation to first-admission rates for psychoses. Br J Psychiatry. 2005;187:401-406.
66. Kelly BD, O'Callaghan E, Waddington JL, et al. Schizophrenia and the city: A review of literature and prospective study of psychosis and urbanicity in Ireland. Schizophr Res. 2010;116:75-89.
67. Lewis G, David A, Andreasson S, Allebeck P. Schizophrenia and city life. Lancet. 1992;340:137-140.
68. Marcelis M, Navarro Mateu F, Murray R, Selten JP, Van Os J. Urbanization and psychosis: a study of 1942-1978 birth cohorths in the Netherlands. Psychol Med. 1998;28:871-879.
69. Pedersen CB, Mortensen PB. Evidence of a dose-response relationship between urbanicity during upbringing and schizophrenia risk. Arch Gen Psychiatry. 2001;58:1039-1046.
70. Kirkbride JB, Fearon P, Morgan C, et al. Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epidemiol. 2007;42:438-445.
71. Selten JP, Slaets JPJ, Kahn RS. Schizophrenia in Surinamese and Dutch Antillean immigrants to the Netherlands: evidence of an increased incidence. Psychol Med. 1997;27:807-811.
72. Johansson LM, Sundquist J, Johansson SE, Bergman B. Immigration: moving house and psychiatric admissions. Acta Psychiatr Scand. 1998;98:105-111.
73. Charalabaki E, Bauwens F, Stefos G, Madianos MG, Mendlewicz J. Immigration and psychopathology: a clinical study. Eur Psychiatry. 1995;10:237-244.
74. Mortensen PB, Cantor-Graae E, McNeil TF. Increased rates of schizophrenia among immigrants: some methodological concerns raised by Danish findings. Psychol Med. 1997;27:813-820.
75. Fearon P, Kirkbride JB, Morgan C, et al. Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP study. Psychol Med. 2006;36:1541-1550.
76. Bebbington PE, Hurry J, Tennant C. Psychiatric disorder in selected groups in Camberwell. Soc Psychiatry. 1981;16:43-51.
77. Castle D, Wessely S, Der G, Murray RM. The incidence of operationally defined schizophrenia in Camberwell, 1965-1984. Br J Psychiatry. 1991;159:790-794.
78. Cochrane R, Bal R. Mental hospital admission rates of immigrants to England: a comparison of 1971 and 1981. Soc Psychiatry. 1989;24:2-11.
79. Dean G, Walsh D, Downing H, Shelley E. First admissions of native born and immigrants to psychiatric hospitals in South East England 1976. Br J Psychiatry. 1981;139:506-512.
80. Harrison G, Owens D, Holten A, Neilson D, Boot D. A prospective study of severe mental disorder in Afro-Caribbean patients. Psychol Med. 1988;18:643-657.
81. McGovern D, Cope R. First psychiatric admission rates of first and second generation Afro-Caribbeans. Soc Psychiatry. 1987;22:139-149.
82. Wessely S, Castle D, Der G, Murray R. Schizophrenia and Afro-Caribbeans. A case-control study. Br J Psychiatry. 1991;159:795-801.
83. Hickling FW, McKenzie K, Mullen R, Murray R. A Jamaican psychiatrist evaluates diagnoses at a London psychiatric hospital. Br J Psychiatry. 1999;175:283-285.
84. Lewis G, Croft-Jeffreys C, David A. Are British psychiatrists racist? Br J Psychiatry. 1990;157:936-937.
85. McGovern D, Hemmings P, Cope R, Lowerson A. Long-term follow-up of young Afro-Caribbean Britons and white Britons with a first admission diagnosis of schizophrenia. 1994;29:8-19.
86. Bhugra D, Hilwig M, Hossein B, et al. First-contact incidence rates of schizophrenia in Trinidad and one-year follow-up. Br J Psychiatry. 1996;169:587-592.
87. Hickling FW, Rodgers-Johnson P. The incidence of first contact schizophrenia in Jamaica. Br J Psychiatry. 1995;167:193-196.
88. Mahy GE, Mallett R, Leff J, Bhugra D. First-contact incidence rate of schizophrenia on Barbados. Br J Psychiatry. 1999;175:28-33.
89. Hutchinson G, Takei N, Fahy TA, et al. Morbid risk of schizophrenia in first-degree relatives of white and African-Caribbean patients with psychosis. Br J Psychiatry. 1996;169:776-780.
90. Boydell J, Van Os J, McKenzie K, et al. Incidence of schizophrenia in ethnic minorities in London: ecological study into interactions with environment. BMJ. 2001;323:1336-1338.
91. Veling W, Susser E, van Os J, Mackenbach JP, Selten JP, Hoek HW. Ethnic density of neighbourhoods and incidence of psychotic disorders among immigrants. Am J Psychiatry. 2007;165:66-73.
92. Agid O, Shapira B, Zislin J, et al. Environment and vulnerability to major psychiatric illness: a case control study of early parental loss in major depression, bipolar disorder and schizophrenia. Mol Psychiatry. 1999;4:163-172.
93. Morgan C, Kirkbride J, Leff J, et al. Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med. 2007;37:495-503.
94. Rutter M. Genes and Behaviour: Nature-Nurture Interplay Explained. Oxford, UK: Blackwell Publishing; 2006.
95. Morgan C, Fisher H. Environment and schizophrenia: environmental factors in schizophrenia: childhood trauma - a critical review. Schizophr Bull. 2007;33:3-10.
96. Arseneault L, Bowes L, Shakoor S. Bullying victimization in youths and mental health problems: 'much ado about nothing'? Psychol Med. 2010;40:717-729.
97. Schreier A, Wolke D, Thomas K, et al. Prospective study of peer victimization in childhood and psychotic symptoms in a nonclinical population at age 12 years. Arch Gen Psychiatry. 2009;66:527-536.
98. Brown GW, Birley JLT. Crises and life changes and the onset of schizophrenia. J Health Soc Behav. 1968;9:203-214.
99. Day R, Neilsen JA, Korten A, et al. Stressful life events preceding the acute onset of schizophrenia: a cross national study from the World Health Organisation. Cult Med Society. 1987;11:123-206.
100. Malla AK, Cortese L, Shaw TS, Ginsberg B. Life events and relapse in schizophrenia: a one year prospective study. Soc Psychiatry Psychiatric Epidemiol. 1990;25:221-224.
101. Ventura J, Nuechterlein KH, Lukoff D, Hardisty JP. A prospective study stressful life events and schizophrenic relapse. J Abnormal Psychol. 1989;98:407-411.
102. Bebbington P, Wilkins S, Jones PB, et al. Life events and psychosis, Initial results from the Camberwell Collaborative Psychosis Study. Br J Psychiatry. 1993;162:72-79.
103. Thornicroft G, Strathdee G, Phelan M, et al. Rationale and design. PRiSM Psychosis Study I. Br J Psychiatry. 1998;173:363-370.
104. Harvey CA, Pantellis C, Taylor J, et al. The Camden schizophrenia surveys. II. High prevalence of schizophrenia in an inner London borough and its relationship to socio-demographic factors. Br J Psychiatry. 1996;168:418-426.
105. Walsh E, Leese M, Taylor PJ, et al. Psychosis in high security and general psychiatric services: report from the UK700 and Special Hospitals' Treatment Resistant Schizophrenia groups. Br J Psychiatry. 2002;180:351-357.
106. Social Exclusion Unit. Mental Health and Social Exclusion. Social Exclusion Unit Report. London, UK: Office of the Deputy Prime Minister; 2004.
107. Marwaha S, Johnson S. Schizophrenia and employment: a review. Soc Psychiatry Psychiatric Epidemiol. 2004;39:337-349.
108. Barnes TR, Hutton SB, Chapman MJ, Mutsatsa S, Puri BK, Joyce EM. West London first-episode study of schizophrenia. Clinical correlates of duration of untreated psychosis. Br J Psychiatry. 2000;177:207-211.
109. Craig TKJ, Garety P, Power P, et al. The Lambeth Early Onset Team: randomised controlled trial of the effectiveness of specialised care for early psychosis. BMJ. 2004;329:1067-1069.
110. Agerbo E, Byrne M, Eaton WW, Mortensen PB. Marital and labour market status in the long run in schizophrenia. Arch Gen Psychiatry. 2004;61:28-33.
111. Morgan C, Kirkbride J, Hutchinson G, et al. Cumulative social disadvantage, ethnicity and first-episode psychosis: a case-control study. Psychol Med. 2008;38:1-15.
112. Van Os J, Linscott RJ, Delespaul MG and Krabbendam L. A systematic review and meta-analysis of the psychosis continuum: evidence for a psychosis proneness-persistence-impairment model of psychotic disorder. Psychol Med. 2009;39:179-195.
113. Johns LC, Cannon M, Singleton N, et al. Prevalence and correlates of self-reported psychotic symptoms in the British population. Br J Psychiatry. 2004;185:298-305.
114. Sharpley M, Hutchinson G, Murray RM, McKenzie K. Understanding the excess of psychosis among the African-Caribbean population in England. Review of current hypotheses. Br J Psychiatry. 2001;40:60-68.
115. Sharpley MS, Peters ER. Ethnicity, class and schizotypy. Soc Psychiatry Psychiatr Epidemiol. 1999;34:507-512.
116. Johns LC, Nazroo JY, Bebbington P, Kuipers E. Occurrence of hallucinatory experiences in a community sample and ethnic variations. Br J Psychiatry. 2002;180:174-178.
117. Janssen I, Krabbendam L, Bak M, et al. Childhood abuse as a risk factor for psychotic experiences. Acta Psychiatr Scand. 2004;109:38-45.
118. Van Os J, Rutten BPF and Poulton R. Gene-environment interactions in schizophrenia: review of epidemiological findings and future directions. Schizophr Bull. 2008;34:1066-1082.
119. Nicodemus KK, Marenco S, Batten AJ, et al. Serious obstetric complications interact with hypoxia-regulated/vascular-expression genes to influence schizophrenia risk. Mol Psychiatry. 2008;13:873-877.
120. Caspi A, Mffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry. 2005;57:1117-1127.
121. Van Os J, Marcelis M. The ecogenetics of schizophrenia. Schizophr Res. 1998;32:127-135.
122. Howes OD, McDonald C, Cannon M, Arseneault L, Boydell J, Murray RM. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacology. 2004;7:7-13.
123. Murray RM, Lappin Julia, Di Forti Marta. Schizophrenia: from developmental deviance to dopamine dysregulation. Eur Neuropsychopharmacol. 2008;18:129-134.
124. Di Forti M, Lappin JM, Murray RM. Risk factors for schizophrenia- all roads lead to dopamine. Eur Neuropsychopharmacol. 2007;17:101-107.
125. Hall FS, Wilkinson LS, Humby T, et al. Isolation rearing in rats: pre- and postsynaptic changes in striatal dopaminergic systems. Pharmacol Biochem Behav. 1998;59:859-872.